CDT Equity Inc.
CDT · CDTTW · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Regan Andrew: Form 4
Insider disclosure · Filed · Report period 22 Oct 2026
-
Form 3
SEC filing · Filed
-
Form 4/A
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 4
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- CDTTW · 20678X114 - *W EXP 09/22/202
- CDT · 20678X502 - Common Stock, par value $0.0001 per share
- CDT · 20678X106 - Common Stock, $0.0001 par value
- CDT · 20678X205 - Common Stock
- CDT · 20678X304 - Common Stock, par value $0.0001 per share
- CDT · 20678X403 - Common Stock, par value $0.0001 per share
- CDT · 20678X700 - Common Stock, par value $0.0001 per share
Company details and SEC sources
CIK 0001896212 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- CDT, CDTTW on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 4851 Tamiami Trail North, Suite 200, Naples, FL, 34103
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- CONDUIT PHARMACEUTICALS INC. (to 07 Aug 2025), Murphy Canyon Acquisition Corp. (to 21 Sep 2023)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields